Pharmaceutical services management capacity and the municipal socioeconomic scenario: persistent inequalities
DOI:
https://doi.org/10.1590/s2175-97902025e231006Keywords:
Pharmaceutical service management, Primary health care, Socioeconomic indicators, Socioeconomic inequalitiesAbstract
The objective of this study was to investigate the relationship between the management capacity of Pharmaceutical Services and socioeconomic indices in Brazilian municipalities, analyzing which contextual factors are involved in its development. Data from a cross-sectional exploratory study at national scale and indicators were used to define the capacity of Pharmaceutical Services management. Pearson’s chi-square test and multivariate analysis were performed to associate Pharmaceutical Services management capacity with socioeconomic indices of each municipality. The results prove the existence of significant relationships between management capacity and socioeconomic indicators, suggesting that management capacity is influenced by the environment in which it operates. Municipalities that presented superior results were those with better socioeconomic indices and better conditions and structure of their healthcare system, reflecting a greater number of professionals, greater participation of popular social control and use of public resources. Municipalities with a smaller population size and lower socio-economic indices have less ability to manage pharmaceutical services, revealing worsening inequalities for its citizens. The existence of an adequate minimum structure, a qualified workforce, service organization, and opportunities for political articulation are essential for such municipalities to develop and improve their management capacity and obtain proper financing based on socioeconomic indicators to facilitate effective access to and adequate use of medicines for the population.
Downloads
References
Álvares J, Alves MCGP, Escuder MML, Almeida AM, Izidoro JB, Junior AAG, et al. National Survey on Access, Use and Promotion of Rational Use of Medicines: methods. Rev Saúde Pública. 2017;51(suppl.2). doi:10.11606/s1518-8787.2017051007027.
Barata RB. Como e por que as desigualdades sociais fazem mal à saúde. Editora Fiocruz; 2009. https://www.arca.fiocruz.br/bitstream/handle/icict/23564/barata9788575413913.pdf?sequence=2&isAllowed=y.
Bernardo NLM, Soares L, Leite SN. A Sociotechnical Approach to Analyze Pharmaceutical Policy and Services Management in Primary Health Care in a Brazilian Municipality. Pharmacy. 2021;9(1):39. doi:10.3390/pharmacy9010039.
Carvalho MN, Álvares J, Costa KS, Junior AAG, Acurcio FA, Costa EA, et al. Workforce in the pharmaceutical services of the primary health care of SUS, Brazil. Rev Saúde Pública. 2017;51(2). doi:10.11606/S1518-8787.2017051007110.
Carvalho MN, Costa EMOD, Sakai MH, Gil CRR, Leite SN. Expansão e diversificação da força de trabalho de nível superior nas Unidades Básicas de Saúde no Brasil, 2008 - 2013. Saúde Debate. 2016;40(109):154-162. doi:10.1590/0103-1104201610912.
Costa EA, Araújo PS, Penaforte TR, Barreto JL, Junior AAG, Acurcio FA, et al. Conceptions on pharmaceutical services in Brazilian primary health care. Rev Saúde Pública. 2017a;51. doi: 10.11606/s1518-8787.2017051007107.
Costa KS, Tavares NUL, Nascimento Júnior JMD, Mengue SS, Álvares J, Junior AAG, et al. Pharmaceutical services in primary health care: interfederative agreement in the development of pharmaceutical policies in the Brazilian Unified Health System (SUS). Rev Saúde Pública. 2017b;51(suppl.2). doi:10.11606/s1518-8787.201705100supl2ap.
David GC, Shimizu HE, Silva EN. Primary Health Care in Brazilian municipalities: efficiency and disparities. Saúde Debate. 2015;39(SPE):232-245. doi: 10.5935/0103-1104.2015s005512.
European Commission, Secretariat-General. European Pillar of Social Rights. Publications Office; 2017. doi:10.2792/95934.
Faraco E, Rover M, Leite S. Avaliação da capacidade de gestão da assistência farmacêutica na Atenção Primária à Saúde dos municípios brasileiros. Cad Saúde Coletiva. 2023. In press.
Faraco EB, Guimarães L, Anderson C, Leite SN. The pharmacy workforce in public primary healthcare centers: promoting access and information on medicines. Pharm Pract (Granada). 2020a;18(4). doi:10.18549/pharmpract.2020.4.2048.
Faraco EB, Rover MM, Farias MR, Leite SN. Desenvolvimento de um protocolo de indicadores para avaliação nacional da capacidade de gestão da Assistência Farmacêutica na Atenção Primária à Saúde. Rev Adm Saúde. 2020b;20(78). doi:10.23973/ras.78.204.
FIP - Fédération Internationale Pharmaceutique. 2012 FIP Global Pharmacy - Workforce Report. 2012. https://www.fip.org/file/1414.
Forte LM, Nobre FC. Avaliação do Índice de Desempenho do SUS (IDSUS) nos Municípios do RN com Vistas à Definição de Estratégias de Gestão. Rev Gest Sist Saúde 2014;03(01):82-93. doi:10.5585/rgss.v3i1.114.
Gerlack LF, Karnikowski MGO, Areda CA, Galato D, Oliveira AG, Álvares J, et al. Gestão da assistência farmacêutica na atenção primária no Brasil. Rev Saúde Pública. 2017;51(2). doi:10.11606/S1518-8787.2017051007063.
Graley CE, May KF, McCoy DC. Postcode Lotteries in Public Health - The NHS Health Checks Programme in North West London. BMC Public Health. 2011;11(1). doi:10.1186/1471-2458-11-738.
Guimarães MC, Santos SM, Melo C, Sanches Filho A. Evaluation of management capacity in social organizations: an in-process methodological proposal. Cad Saude Publica. 2004;20(6):1642-1650. doi:10.1590/s0102-311x2004000600023.
IBGE - Instituto Brasileiro de Geografia e Estatística. Indicadores Sociais Municipais: Uma Análise Dos Resultados Do Universo Do Censo Demográfico 2010. 2011. https://biblioteca.ibge.gov.br/biblioteca-catalogo?id=254598&view=detalhes.
Leite SN, Farias MR, Manzini F, Mendes SJ, Rover MRM, eds. Gestão Da Assistência Farmacêutica: Proposta Para Avaliação No Contexto Municipal: A Experiência Em Santa Catarina 2015. Editora da UFSC; 2015:170.
Leite SN, Manzini F, Adelir V, Lima MEO, Pereira MA, Araujo SQ, et al. Ciência, Tecnologia e Assistência Farmacêutica em pauta: contribuições da sociedade para a 16a Conferência Nacional de Saúde. Cien Saude Colet. 2018;23(12):4259-4268. doi:10.1590/1413-812320182312.29962018.
Lorenzetti J, Lanzoni GMDM, Ferreira L, Pires DEP, Ramos FRS. Health management in Brazil: dialogue with public and private managers. Texto e Contexto – Enferm. 2014;23(2):417-442. doi:10.1590/0104-07072014000290013.
Maceira D, Brumana L, Aleman JG. Reducing the equity gap in child health care and health system reforms in Latin America. Int J Equity Health. 2022;21(1). doi:10.1186/s12939-021-01617-w.
Manzini F, Diehl EE, Farias MR, Santos RI, Soares L, Rech Norberto, et al. Analysis of a Blended, In-Service, Continuing Education Course in a Public Health System: Lessons for Education Providers and Healthcare Managers. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.561238.
Massuda A, Hone T, Leles FAG, Castro MC, Atun R. The Brazilian health system at crossroads: progress, crisis and resilience. BMJ Global Health. 2018;3(4). doi:10.1136/bmjgh-2018-000829.
Mendes Á, Leite MG, Carnut L. A methodology for apportioning federal SUS resources: the health needs index. Rev Saude Publica. 2020;54(77). doi:10.11606/s1518-8787.2020054001661.
Mendes J, Peixoto R, Leite SN. Fatores sociais e técnicos relacionados ao desenvolvimento da gestão municipal da Assistência Farmacêutica: resultados do QUALIFICA_AF. Rev Saude Debate. 2024. In press.
Mendonça CS, Diercks MS, Kopittke L. Strengthening Primary Health Care in the municipalities in the Metropolitan Region of Porto Alegre, Brazil, after the introduction of the Mais Médicos (More Doctors) Program: an inter-municipal comparison. Cien Saude Colet. 2016;21(9):2871-2878. doi:10.1590/1413-81232015219.16622016.
Minaei H, Peikanpour M, Yousefi N, Peymani P, Peiravian F, Shobeiri N, et al. Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country. Iran J Pharm Res. 2019;18(4):2191-2203. doi:10.22037/ijpr.2019.111636.13273.
Ministério da Saúde (Brasil). Ordinance no. 2077, of September 17, 2012. Establishes the National Survey on Access, Use and Promotion of Rational Use of Medicines in Brazil (PNAUM). https://bvsms.saude.gov.br/bvs/saudelegis/gm/2012/ prt2077_17_09_2012.
Ministério da Saúde (Brasil). Ordinance no. 3193, of December 9, 2019. Amends Consolidation Ordinance No. 6/GM/MS, of September 28, 2017, to provide for the financing of the Basic Component of Pharmaceutical Assistance within the scope of the Unified Health System (SUS). https://bvsms.saude.gov.br/bvs/saudelegis/gm/2019/prt3193_10_12_2019.html.
Oliveira LR, Passador CS. The Brazilian Unified National Health System: Proposal of a Cost-effectiveness Evaluation Model. BAR - Braz Admin Review. 2016;13(2). doi: 10.1590/1807-7692bar2016140120.
Pereira NC, Luiza VL, Campos MR, Chaves LA. Implementation of pharmaceutical services in Brazilian primary health care: a cross-sectional study. BMC Fam Pract. 2021;22(1). doi:10.1186/s12875-021-01516-7.
Reis AT, Oliveira P TR, Sellera PE. Sistema de Avaliação para a Qualificação do Sistema Único de Saúde (SUS). Rev Eletron Comun Inf Inov Saúde. 2012;6(2). doi: 10.3395/reciis.v6i2.543.
Rocha S. Renda E Pobreza - Medidas per Capita versus Adulto-Equivalente; 1998. https://repositorio.ipea.gov.br/bitstream/11058/2487/1/td_0609.pdf.
Rocha WH, Teodoro JÁ, Acurcio FA, Junior AAG, Moura ICG, Godman Brian, et al. Influence of pharmaceutical services organization on the availability of essential medicines in a public health system. J Comp Eff Res. 2021;10(6):519-532. doi:10.2217/cer-2020-0259.
Rover MR, Vargas-Pelaez CM, Farias MR, Leite SN. Acceso a medicamentos de alto precio en Brasil: la perspectiva de médicos, farmacéuticos y usuarios. Gac Sanit. 2016;30(2):110-116. doi:10.1016/j.gaceta.2015.12.005.
Vogler S, Österle A, Mayer S. Inequalities in medicine use in Central Eastern Europe: an empirical investigation of socioeconomic determinants in eight countries. Int J Equity Health. 2015;14(1). doi:10.1186/s12939-015-0261-0.
WHO - World Health Organization Expert Committee on the Selection and Use of Essential Medicines (12th:2002:Geneva, Switzerland), World Health Organization. The Selection and Use of Essential Medicines : Report of the WHO Expert Committee, 2002 : (Including the 12th Model List of Essential Medicines). World Health Organization; 2003. https://apps.who.int/iris/handle/10665/42620.
WHO - World Health Organization. Roadmap for access to medicines, vaccines and health product 2019-2023: comprehensive support for access to medicines, vaccines and other health products. World Health Organization. Published 2019. https://apps.who.int/iris/handle/10665/330145.
Willemann MCA, Medeiros JM de, Lacerda JT, Calvo MCM. Atualização intercensitária de estratificação de municípios brasileiros para avaliação de desempenho em saúde, 2015. Epidemiol Serv Saúde. 2019;28(3). doi:10.5123/s1679-49742019000300004.
Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, Joncheere CP, Ewen MA, et al. Essential medicines for universal health coverage. Lancet. 2017;389(10067):403-476. doi:10.1016/s0140-6736(16)31599-9.
Downloads
Published
Data Availability Statement
Not informed.
Issue
Section
License
Copyright (c) 2025 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
